Most State AI Policies Overlook Health-Specific Guidance, but One New Example Focuses on Accuracy and Trust
Questions about how generative AI tools could affect public trust and the accuracy of AI-generated information are among factors contributing to new governmental policies around AI use. According to an analysis of publicly available AI policies published last month by the Association of State and Territorial Health Officials (ASTHO), most of these plans focus on government-wide issues, such as data privacy and security, procurement, and vendor requirements. Some provisions, like requirements for human review and disclosure of AI use, may apply to health agencies within those jurisdictions. The analysis found, though, that few of the policies addressed health-specific applications directly, such as evaluating AI tools for disease surveillance or outbreak detection, and most health-specific policies that do exist are not public.
One publicly available example from a health agency comes from the public health department of Ashland County, Ohio, which unanimously approved and released its own AI governance policy last month. The policy provides a look at how one health agency is approaching AI use, explicitly identifying public trust and the accuracy of AI-generated information as core considerations for the responsible use of AI in health care. The policy states that AI should be used in ways that “promote transparency, accountability, and community confidence.” Among other rules, staff are required to verify factual claims, citations, and statistics generated by AI before relying on them, and human review is required for most non-minor uses of AI to ensure accuracy. The policy also establishes an incident reporting framework for when AI-assisted work might include false information, treating errors where hallucinations enter published materials as incidents to be tracked and addressed. Beyond these general rules, the policy lays out health-specific approved AI use cases, including de-identified data analysis in epidemiology, health promotion content in nursing, and inspection communication templates in environmental health. It also states that no AI system may independently make clinical, regulatory, or public health decisions on behalf of the agency.
Because the Ashland County policy is publicly available, it offers the public, other health organizations, and researchers a look at how one health agency is trying to maintain accuracy and protect trust in its use of the technology, which has relatively low trust among the public overall for health information. KFF’s March 2026 Tracking Poll on Health Information and Trust found that a third of adults (33%) said they had a “great deal” or “fair amount” of trust in AI tools or chatbots to provide reliable information about health.
What to Watch Out For
As health agencies continue incorporating AI tools into their work and developing their own more tailored guidelines, could transparently communicating about their approaches to governing AI use impact public trust? More research on what the public expects from agencies using AI could help clarify how these policies might affect confidence in health agencies (which has declined since the COVID-19 pandemic) and the information they provide.
Some Medical Journals Are Responding to a Rise in AI-Generated Citations
Researchers have documented a rise in fabricated references across medical research, with some citations referencing studies that do not exist or do not support the claims attributed to them. One correspondence published earlier this year identified thousands of fake citations across millions of papers, with the rates climbing sharply after generative AI tools became widely available. Many of the references were difficult to distinguish from legitimate studies, pairing real authors and plausible titles with studies that were never published.
Some medical journals have begun to respond to the challenge of AI-fabricated citations, including by requiring disclosure when AI is used, but an analysis of 5,114 journals and over 5.2 million papers found that AI use without disclosure continues despite these policies. JAMA updated its guidance for authors last month in response to the journal’s own experience receiving manuscripts with inaccurate or nonexistent references and research showing that rates of author disclosure of AI use in submissions to their journal have remained low. Rather than requiring disclosure when AI contributes to references, JAMA’s approach advises against using AI to generate, format, or manage citations, and directs authors to standard reference managers instead.
Why This Matters
Fabricated citations carry the appearance of legitimate sourcing, making them difficult to catch without deliberate verification. Disclosure policies alone have not solved the problem, leading one major journal to move toward restricting AI’s use for generating references rather than asking authors to report it.
Comments